The Journal of Steroid Biochemistry and Molecular Biology
7α- and 7β-hydroxy-epiandrosterone as substrates and inhibitors for the human 11β-hydroxysteroid dehydrogenase type 1
Introduction
In the human liver and brain, the cytochrome P4507B1 (CYP7B1) catalyzes the 7α-hydroxylation of 3β-hydroxysteroids [1]. Thus, 7α-hydroxy-dehydroepiandrosterone (7α-hydroxy-DHEA) and 7α-hydroxy-epiandrosterone (7α-hydroxy-EpiA) are produced out of DHEA and EpiA substrates, respectively. We showed that in addition to 7α-hydroxy-DHEA and 7α-hydroxy-EpiA, the human P4507B1 produced small quantities of the 7β-hydroxylated epimers that were assessed as a side production because of KM identical with that of 7α-hydroxylation but showing much lower Kcat [1]. The production yields of 7β-hydroxylated derivatives were not sufficient for a full explanation of the almost equivalent quantities of 7α- and 7β-hydroxy-DHEA found in the human body fluids [2], [3], [4], and several hypotheses were discussed. This and the report of Robinzon et al. [5] led us to consider the human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) as responsible for the inter-conversion of 7α- and 7β-hydroxy-DHEA. Indeed the yeast-expressed human 11β-HSD1 carried out the inter-conversion of both steroids through an oxido-reduction process involving a 7-oxo-DHEA intermediate [6]. This was also confirmed in human liver S9 fractions where both 7α- and 7β-hydroxy-DHEA gave rise to inter-conversion through production of 7-oxo-DHEA [7]. Curiously, the use of 7α- and 7β-hydroxy-EpiA substrates with the same S9 fractions led to inter-conversion without a trace of the putative 7-oxo-EpiA intermediate [7], and this was also observed when human intestine microsomes were used [8]. This leads to question whether the 11β-HSD1-mediated inter-conversion process is identical for the DHEA and EpiA derivatives, and whether 7α- and 7β-hydroxy-EpiA could behave as well as 7α- and 7β-hydroxy-DHEA for inhibition of the 11β-HSD1-mediated cortisone/cortisol inter-conversion (unpublished data).
In this work, our aims were to use the previously produced yeast-expressed human 11β-HSD1 [6] and NADP+ or NADPH-regenerating systems for kinetic studies of the inter-conversion process with use of 7α-hydroxy-EpiA, 7β-hydroxy-EpiA and 7-oxo-EpiA substrates. Finally, we wanted to study their inhibition potencies on the 11β-HSD1-mediated cortisol/cortisone oxido-reduction.
Section snippets
Steroids and reagents
7β-Hydroxy-EpiA (HF0220) was a gift from Hunter-Fleming Ltd. (Bristol, UK). Custom chemical synthesis by Roowin S.A. (Romainville, France) provided milligram quantities of chemically pure 7α-hydroxy-EpiA, and 7-oxo-DHEA-17-ethylene-ketal. The latter steroid was reduced with hydrogen gas in the presence of Pd into 3β-hydroxy-5α-androstane-17-ethylene-ketal,7-one. After HCl treatment, the 3β-hydroxy-5α-androstane-7,17-dione was obtained and purified by preparative HPLC. Identity and purity of the
11β-HSD1-mediated transformation of 7-oxygenated EpiA
The three 7-oxygenated steroids, namely 7-oxo-EpiA, 7α-hydroxy-EpiA and 7β-hydroxy-EpiA, were used as substrates for the recombinant 11β-HSD1 after supplementation with either the NADPH- or the NADP+-regenerating system. The substrate and metabolite extracted were separated by HPLC and their major ions detected by the coupled MS (Table 1). Ions with m/z 287.6 and 289.6 were selected for the detection of 7-oxo-EpiA and 7-hydroxy-EpiA, respectively. Under oxidative conditions (NADP+-regenerating
Discussion
In this study, the recombinant human 11β-HSD1 enzyme expressed in S. cerevisiae was the same as the one previously used to compare of its action on the classical cortisol–cortisone substrates with its inter-converting properties for 7α- and 7β-hydroxy-DHEA substrates [6]. We stated that other authors had over-expressed the human 11β-HSD1 in yeast with use of Pichia pastoris strains [16] and that microsomes of human liver and the recombinant yeast provided the same KMs when cortisone reduction
Acknowledgements
This work was supported by a grant from Hunter-Fleming Inc. (UK). We thank Patrice Rool (Roowin S.A., Romainville, France) for the gift of EpiA derivatives.
References (23)
- et al.
The human cytochrome P4507B1: catalytic activity studies
J. Steroid Biochem. Mol. Biol.
(2004) - et al.
Immunoassay of 7-hydroxysteroids. 1. Radioimmunoassay of 7 beta-ydroxydehydroepiandrosterone
J. Steroid Biochem. Mol. Biol.
(1998) - et al.
Immunoassay of 7-hydroxysteroids. 2. Radioimmunoassay of 7 alpha-hydroxy-dehydroepiandrosterone
J. Steroid Biochem. Mol. Biol.
(1999) - et al.
7-Hydroxydehydroepiandrosterone epimers in human serum and saliva. Comparison of gas chromatography–mass spectrometry and radioimmunoassay
J. Chromatogr. A
(2001) - et al.
Glucocorticoids inhibit interconversion of 7-hydroxy and 7-oxo metabolites of dehydroepiandrosterone: a role for 11beta-hydroxysteroid dehydrogenases?
Arch. Biochem. Biophys.
(2003) - et al.
Inter-conversion of 7alpha- and 7beta-hydroxy-dehydroepiandrosterone by the human 11beta-hydroxysteroid dehydrogenase type 1
J. Steroid Biochem. Mol. Biol.
(2006) - et al.
Neurosteroids: metabolism in human intestine microsomes
Steroids
(2005) - et al.
The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization
J. Biol. Chem.
(1991) - et al.
Dehydroepiandrosterone and its 7-hydroxylated metabolites do not interfere with the transactivation and cellular trafficking of the glucocorticoid receptor
J. Steroid Biochem. Mol. Biol.
(2004) - et al.
Yeast expression of animal and plant P450s in optimized redox environments
Methods Enzymol.
(1996)